“Fresh ideas and multiple disciplines are needed to advance Temporomandibular Disorders (TMDs) research to improve patient care. The National Institutes of Health (NIH) provides approximately one third of all biomedical research funding in the United States and therefore, the interests and priorities of NIH Institutes and Centers can stimulate research interests and training programs throughout the country. TMDs are not the primary mission of any NIH Center or Institute.” (NAM report, Summary S-5)

NIH Grant Funding Opportunities

We invite you to view a list of the latest National Institutes of Health (NIH) funding opportunities for scientists interested in advancing TMJ research.

Table of Opportunities

Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites Planning Grant applications that conceptualize the design and implementation of a future national, interdisciplinary, patient-centered research collaborative that will advance Temporomandibular Disorders (TMDs) basic and clinical research, research training, and translation to evidence-based treatments and improved clinical care. The planning grants are intended to enable institutions to develop partnerships, infrastructure, and capabilities needed to address the major goals of a future Collaborative and develop a Collaborative-wide research framework and strategies to support coordination among studies, research projects, and sites, and thereby enhance competitiveness for future participation in TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT).

The planning grant will not be a prerequisite for submission of a TMD IMPACT application.


The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 applications on the influence and intersection of sex and gender in health and disease, including: (1) research applications that examine sex and gender factors and their intersection in understanding health and disease; and (2) research that addresses one of the five objectives from Strategic Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women’s Health Research “Advancing Science for the Health of Women.” The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Women’s Health (ORWH) and the scientific partnering Institutes and Centers across NIH.


Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)

The TMJA welcomes the announcement by the NIH Office of Research on Women’s Health of the availability of Administrative Supplements to support research on the health of women in understudied, underrepresented, and underreported populations in biomedical research. The prevalence of TMJ is higher in women and yet support for biomedical research specifically targeted to sex and gender topics in TMJ is lacking. Clearly, more research is needed to address molecular, genetic, musculoskeletal, endocrine, neurological, and bio-behavioral aspects of TMJ in women. We hope this announcement will result in many new avenues of research that will clarify the causes of TMJ, elucidate the arc of disease progression, and ultimately, hasten the development of precision treatments for TMJ patients.